title: Uric acid inhibits placental system A amino acid uptake.
abstract: Hyperuricemia, a common clinical characteristic of preeclamptic pregnancies, has historically been considered a marker of reduced renal function in preeclamptic women. More recently it has been suggested that uric acid may directly contribute to pathological cell signaling events involved in disease progression as well as maternal and fetal pregnancy outcomes including fetal growth restriction. We hypothesize that the increased frequency of restricted fetal growth seen in relation to increasing uric acid concentrations in preeclamptic women is in part the result of uric acid-induced reductions in amino acid transport across the placenta. The objective of the current study was to examine the effects of uric acid on human placental System A amino acid transport using a primary placental villous explant model. Further, we examined the necessity of uric acid uptake and the role of redox signaling as a potential mechanism through which uric acid may attenuate System A activity. Placental uptake of a radiolabeled amino acid analogue, specific to the System A transporter, was reduced in a concentration-dependent fashion with increasing uric acid (0-7 mg/dL), corresponding to uric acid concentrations measured in healthy pregnant and preeclamptic women in the third trimester. Uric acid-induced reduction in System A activity was partially reversed by NADPH oxidase inhibition and completely eliminated by antioxidant treatment. This study demonstrates inhibition of placental System A amino acid transport with uric acid treatment, as a result of uric acid-induced stimulation of intracellular redox signaling cascades. These findings may be relevant to the increased frequency of fetal growth restriction observed in hyperuricemic preeclampsia. Additionally the results of this study, indicating a detrimental effect of hyperuricemia on amino acid transport in the placenta, at concentrations present in women with preeclampsia, also suggest a role for uric acid in the pathophysiology of preeclampsia.
authors.affiliation: Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA. shannon.bainbridge@gmail.com
authors.forename: S A
authors.initials: SA
authors.lastname: Bainbridge
authors.forename: F
authors.initials: F
authors.lastname: von Versen-Höynck
authors.forename: J M
authors.initials: JM
authors.lastname: Roberts
mesh_terms: D000098:Acetophenones / Q000494:pharmacology; D000328:Adult; D026924:Amino Acid Transport System A / Q000378:metabolism*; D000596:Amino Acids / Q000378:metabolism*; D000975:Antioxidants / Q000494:pharmacology; D002470:Cell Survival / Q000187:drug effects; D002824:Chorionic Villi / Q000187:drug effects* / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D006801:Humans; D019255:NADPH Oxidases / Q000037:antagonists & inhibitors; D009924:Organ Culture Techniques; D018384:Oxidative Stress / Q000187:drug effects; D011225:Pre-Eclampsia / Q000378:metabolism; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D014527:Uric Acid / Q000494:pharmacology*; D055815:Young Adult
chemical_list: D000098:Acetophenones; D026924:Amino Acid Transport System A; D000596:Amino Acids; D000975:Antioxidants; D004791:Enzyme Inhibitors; D014527:Uric Acid; C056165:acetovanillone; D019255:NADPH Oxidases